Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes

Lignende værker

• Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes
  af: Ma, Zhulin, et al.
  Udgivet: (2014)
• Explorative Study of Pharmacokinetics and Pharmacodynamics after Change in Basal Insulin Infusion Rate
  af: Ihlo, Charlotte A., et al.
  Udgivet: (2011)
• Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions
  af: McVey, Elaine, et al.
  Udgivet: (2015)
• Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion
  af: Dogan, Ayse Dudu Altintas, et al.
  Udgivet: (2016)
• An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
  af: Baker, J., et al.
  Udgivet: (2020)